Institutional Ownership
Editas Medicine Inc
CUSIP 28106W103COMEDITQ1 2026
13D / 13G Filings
35
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
17.1%
Max % of class reported
Institutional Holders
201
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
35 filings · latest Apr 17, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 7.9% | 6.54M | SEC |
| 2 | Feb 14, 2025 | Deep Track Capital, LP | 13G/A | — | — | SEC |
| 3 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 8.1% | 6.68M | SEC |
| 4 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 8.1% | 6.68M | SEC |
| 5 | Oct 17, 2024 | State Street Corp | 13G/A | 3.0% | 2.46M | SEC |
| 6 | Jul 10, 2024 | State Street Corp | 13G/A | 5.6% | — | SEC |
| 7 | Apr 10, 2024 | State Street Corp | 13G/A | 10.7% | — | SEC |
| 8 | Feb 14, 2024 | Deep Track Capital, LP | 13G/A | 6.7% | 5.47M | SEC |
| 9 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 10.4% | 8.46M | SEC |
| 10 | Jan 24, 2024 | Blackrock Inc. | 13G/A | 9.6% | 7.84M | SEC |
25 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Editas Medicine Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 9.26M | $22.88M |
| 2 | Renaissance Technologies LLC | 3.97M | $9.81M |
| 3 | Geode Capital Management, LLC | 2.31M | $5.71M |
| 4 | State Street Corp | 2.08M | $5.13M |
| 5 | Nuveen, LLC | 1.98M | $4.88M |
| 6 | D. E. Shaw & Co., Inc. | 1.94M | $4.80M |
| 7 | Opaleye Management Inc. | 1.93M | $4.76M |
| 8 | Jpmorgan Chase & Co | 1.95M | $4.34M |
| 9 | Two Sigma Investments, LP | 1.55M | $3.83M |
| 10 | Aqr Capital Management LLC | 1.37M | $3.39M |